Ads should hit the heart
This article was originally published in The Rose Sheet
Executive Summary
Advertisers should craft their ads around creativity and emotion and not factual content to build strong brand relationships, a study published in the December issue of Journal of Advertising Research finds. Robert Heath, School of Management, University of Bath, UK, worked with research firm OTX to assess the rational and emotional content of 23 on-air ads in the U.S. and 20 in the UK. They then surveyed 200 people in each country to gauge their responses to the featured brands. "The results confirm that favorability towards brands is strongly correlated with emotional content in advertising, but not with factual content," Heath states. Content-driven messages fade faster than those recommended via emotional meta-communication, he says, noting that subtle emotional elements are more likely to work "because the viewer has less opportunity to rationally evaluate, contradict and weaken their potency." Also, "high attention weakens the effect of emotional content," so ads might be more effective "processed at lower levels of attention"...
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.